Results 51 to 60 of about 76,842 (216)

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

open access: yes, 2002
Nonmyeloablative conditioning is increasingly used for transplantation in a wide range of diseases, but little is known about its impact on the incidence of infections and immune reconstitution.
Mahendra, P   +44 more
core   +1 more source

Hematopoietic stem cell transplantation in Oman [PDF]

open access: yesBone Marrow Transplantation, 2008
Hematopoietic SCT (HSCT) is an integral part of the management of patients with hematologic disorders. The Sultanate of Oman, with a population of 2.3 million, has an HSCT program based in the Sultan Qaboos University (SQU) hospital. Initiated in 1995, this two-bed unit continues to be the only program in the country. Between June 1995 and August 2006,
D, Dennison   +13 more
openaire   +2 more sources

Association between oral and fecal microbiome dysbiosis and treatment complications in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation

open access: yesScientific Reports
The oral and gastrointestinal mucosae represent the main targets of the toxic effect of chemo and/or radiotherapy administered during the conditioning regimen before hematopoietic stem cell transplant (HSCT).
M. Faraci   +13 more
doaj   +1 more source

Intractable myoclonic seizures in an allogeneic stem cell transplant recipient: A rare case of myoclonic epilepsy

open access: yesEpilepsy and Behavior Case Reports, 2015
Introduction: Myoclonus may be a rare complication of stem cell transplant but has limited discussion in the scientific literature. Case: We present a case of an acute myeloid leukemia survivor who developed refractory myoclonic epilepsy four years after
Anna Robuccio   +4 more
doaj   +1 more source

Massive periorbital edema following hematopoietic stem cell transplantation

open access: yesAmerican Journal of Ophthalmology Case Reports, 2022
Purpose: To describe a case of severe, bilateral periorbital edema after hematopoietic stem cell transplantation. Observations: A three-year old girl with metastatic neuroblastoma underwent the second of two tandem autologous peripheral blood stem cell ...
Jeannette Y. Stallworth   +1 more
doaj   +1 more source

Clonal karyotype evolution involving ring chromosome 1 with myelodysplastic syndrome subtype RAEB-t progressing into acute leukemia [PDF]

open access: yes, 2006
s Karyotypic evolution is a well-known phenomenon in patients with malignant hernatological disorders during disease progression. We describe a 50-year-old male patient who had originally presented with pancytopenia in October 1992.
Wunderlich, Bettina   +18 more
core   +1 more source

Neuromuscular electrical stimulation for physical function maintenance during hematopoietic stem cell transplantation: Study protocol.

open access: yesPLoS ONE
Hematopoietic stem cell transplantation is a common life-saving treatment for hematologic malignancies, though can lead to long-term functional impairment, fatigue, muscle atrophy, with decreased quality of life.
Lindsey J Anderson   +6 more
doaj   +1 more source

Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years’ experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases

open access: yesHaematologica, 2010
Background Autologous hematopoietic stem cell transplantation has been used since 1996 for the treatment of severe autoimmune diseases refractory to approved therapies.
Dominique Farge   +13 more
doaj   +1 more source

Hematopoietic Stem Cell Transplantation for MDS [PDF]

open access: yesHematology/Oncology Clinics of North America, 2010
Hematopoietic stem cell transplantation (HSCT) offers potentially curative therapy for patients with myelodysplastic syndromes (MDS). However, as the majority of patients with MDS are in the seventh or eighth decade of life, conventional transplant regimens have been used only infrequently, and only with the development of reduced-intensity ...
Matthias, Bartenstein, H Joachim, Deeg
openaire   +2 more sources

Age Adjusted Comorbidity Risk Index Does Not Predict Outcomes in an Autologous Hematopoietic Stem Cell Transplant Population

open access: yesCell Transplantation, 2022
The hematopoietic comorbidity risk index (HCT-CI) is a pre-transplant risk assessment tool used to prognosticate morbidity and mortality of patients undergoing allogeneic hematopoietic stem cell transplantation.
Dylan Barth   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy